| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8649525 | Cardiovascular Revascularization Medicine | 2017 | 6 Pages | 
Abstract
												In patients with an established indication for OAC undergoing PCI-S, non-low bleeding risk category is the most potent independent predictor of major bleeding. Stratification of the bleeding risk at baseline should therefore be regarded as an indispensable process to be carried out before selection of the antithrombotic therapy.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Molecular Medicine
												
											Authors
												Andrea Rubboli, Francesco Saia, Alessandro Sciahbasi, Antonio M. Leone, Cataldo Palmieri, Maria Letizia Bacchi-Reggiani, Paolo Calabrò, Barbara Bordoni, Giacomo Piccalò, Nicoletta Franco, Annamaria Nicolino, Paolo Magnavacchi, Luigi Vignali, 
											